Clinical Trial

CULTURALLY ADAPTED DIALECTICAL BEHAVIOR THERAPY FOR LOW-MIDDLE-INCOME COUNTRIES

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 28, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study aims to assess the efficacy of culturally adapted dialectical behaviour therapy (DBT) for addressing emotional dysregulation in a low- and middle-income country, as well as to evaluate the impact of DBT on secondary outcomes such as borderline personality traits, self-harm or suicide, depression, anxiety, and individuals' functioning and disability. Through a rigorous Randomised Controlled Trial (RCT), the research seeks to assess how cultural adaptations of dialectical behaviour therapy improve its applicability, engagement, and outcomes in diverse socio-cultural settings, contributing to more accessible and effective mental health interventions in resource-limited regions.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-15.
Trial Details
NCT Number NCT07239362
Lead Sponsor Pakistan Association of Cognitive Therapists
Conditions Borderline Personality Disorder (BPD), Dialectical Behavior Therapy, Emotional Dysregulation, Self Harm, Suicidal and Self-injurious Behavior, Depression Anxiety Disorder
Enrollment 220 participants
Start Date 2025-11-20
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-28